The DOI matches its Crossref record; 40 of the 43 references it cites were found in a registry or an index.
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To quantify the effectiveness of pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance. DATA SOURCES: Medline, Embase, and the Cochrane library searched up to July 2006. Expert opinions sought and reference lists of identified studies and any relevant published reviews checked. STUDY SELECTION: Randomised controlled trials that evaluated interventions to delay or prevent type 2 diabetes in individuals with impaired glucose tolerance. RESULTS: 21 trials met the inclusion criteria, of which 17, with 8084 participants with impaired glucose tolerance, reported results in enough detail for inclusion in the meta-analyses. From the meta-analyses the pooled hazard ratios were 0.51 (95% confidence interval 0.44 to 0.60) for lifestyle interventions v standard advice, 0.70 (0.62 to 0.79) for oral diabetes drugs v control, 0.44 (0.28 to 0.69) for orlistat v control, and 0.32 (0.03 to 3.07) for the herbal remedy jiangtang bushen recipe v standard diabetes advice. These correspond to numbers needed to treat for benefit (NNTB) and harm (NNTH) of 6.4 for lifestyle (95% credible interval, NNTB 5.0 to NNTB 8.4), 10.8 for oral diabetes drugs (NNTB 8.1 to NNTB 15.0), 5.4 for orlistat (NNTB 4.1 to NNTB 7.6), and 4.0 for jiangtang bushen (NNTH 16.9 to NNTB 24.8). CONCLUSIONS: Lifestyle and pharmacological interventions reduce the rate of progression to type 2 diabetes in people with impaired glucose tolerance. Lifestyle interventions seem to be at least as effective as drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Our findings that both lifestyle and metformin interventions delayed or prevented diabetes in the DPPOS are consistent with results of other reports of similar interventions with lifestyle or with other antidiabetic drugs.24,25”
From 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) · cites this paper as [25]
In the citing paper
“Sixteen of these systematic reviews included exclusively people with intermediate hyperglycaemia (Aguiar 2014; Gillett 2012; Gillies 2007; Glechner 2015; Gong 2015; Hopper 2011; ICER 2016; Norris 2005; Santaguida 2005; Selph 2015; Stevens 2015; Yamaoka 2005; Yates 2007; Yoon 2013; Yuen 2010; Zheng 2016);”
From Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus (2017) · cites this paper as Gillies 2007
In the citing paper
“In their systematic review, Gillies et al. found that lifestyle and pharmacological interventions reduced the rate of progression to type 2 diabetes in people with IGT and that these interventions seem to be as effective as pharmacological treatment.”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,557
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24 · Cited by 4,519
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Self-citation
Research works printed but not linked: 3
- [4]4. Angelo JB, Huang J, Carden D. Diabetes prevention: a review of current literature. Adv Stud Med 2005;5:250-9.
- [19]19. World Health Organization Expert Committee. Diabetes mellitus, second report. World Health Organ Tech Rep Ser 1980;646:1-80.
- [20]20. WHO Study Group. Diabetes mellitus. World Health Organ Tech Rep Ser 1985;727:1-113.
Cited by
Sorted by citations
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10001 · Cited by 1,420
The IMAGE Study Group, Greaves, C. J., Sheppard, K. E., Abraham, C., Hardeman, W., Roden, M., Evans, P. H., & Schwarz, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-119 · Cited by 1,163
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Forouhi, N. G., & Wareham, N. J. (2014) · Medicine · doi:10.1016/j.mpmed.2014.09.007 · Cited by 778
Genotype score in addition to common risk factors for prediction of type 2 diabetes
Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W. F., D'Agostino, R. B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804742 · Cited by 759
Carter, P., Gray, L. J., Troughton, J., Khunti, K., & Davies, M. J. (2010) · BMJ · doi:10.1136/bmj.c4229 · Cited by 728
Self-citationTang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
Prevention of Diabetes With Mediterranean Diets: A Subgroup Analysis of a Randomized Trial
Salas-Salvadó, J., Bulló, M., Estruch, R., Ros, E., Covas, M.-I., Ibarrola-Jurado, N., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1725 · Cited by 650
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G. E., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S. E., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 646
Translating the Diabetes Prevention Program into the Community
Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H., & Marrero, D. G. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.06.035 · Cited by 622
Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Jelleyman, C., Yates, T., O'Donovan, G., Gray, L. J., King, J. A., Khunti, K., & Davies, M. J. (2015) · Obesity Reviews · doi:10.1111/obr.12317 · Cited by 588
Self-citationMetformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
(DPS), F. T. F. D. P. S., Lindström, J., Peltonen, M., Eriksson, J. G., Ilanne-Parikka, P., Aunola, S., Keinänen-Kiukaanniemi, S., Uusitupa, M., & Tuomilehto, J. (2013) · Diabetologia · doi:10.1007/s00125-012-2752-5 · Cited by 551
Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182285a81 · Cited by 541
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542
Self-citationThe Growing Epidemic of Diabetes Mellitus
Lović, D. B., Piperidou, A., Zografou, I., Grassos, H., Pittaras, A. E., & Manolis, A. J. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165911 · Cited by 571
Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature
Dawish, M. A. A., Robert, A. A., Braham, R. B., Hayek, A. A., Saeed, A. H. A., Ahmed, R. A., & Sabaan, F. S. A. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150724095130 · Cited by 510
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Magkos, F., Hjorth, M. F., & Astrup, A. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0381-5 · Cited by 507
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P. E., Lindström, J., Lalic, N. M., Greaves, C. J., McKee, M., Kissimova‐Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 485
Lower circulating irisin is associated with type 2 diabetes mellitus
Liu, J., Wong, M. D. S., Toy, W. C., Tan, C., Liu, S., Ng, X. W., Subramaniam, T., Sum, C. F., & Lim, S. C. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.03.002 · Cited by 453
Milat, A., King, L., Bauman, A. E., & Redman, S. (2012) · Health Promotion International · doi:10.1093/heapro/dar097 · Cited by 439
Li, M., Fan, Y., Zhang, X., Hou, W., & Tang, Z. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005497 · Cited by 417
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Jagannathan, R., Patel, S. A., Ali, M. K., & Narayan, K. M. V. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1161-2 · Cited by 391
Use of Indirect and Mixed Treatment Comparisons for Technology Assessment
Sutton, A. J., Ades, A. E., Cooper, N. J., & Abrams, K. R. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00006 · Cited by 354
Self-citationHaw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
Ramachandran, A., Snehalatha, C., Ram, J., Selvam, S., Simon, M., Nanditha, A., Shetty, A. S., Godsland, I. F., Chaturvedi, N., Majeed, A., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70067-6 · Cited by 330
Li, C., Ford, E. S., Zhao, G., & Mokdad, A. H. (2009) · Diabetes Care · doi:10.2337/dc08-1128 · Cited by 340
“Because pre-diabetes is an intermediate stage in the development of type 2 diabetes and has been shown to be reversible through pharmacological and lifestyle interventions (20), Table 2—Unadjusted and adjusted prevalence ratios for pre-diabetes among nondiabetic U.”
BackgroundWang, P., Fang, J., Zong-hua, G., Zhang, C. M., & Xie, S. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12376 · Cited by 352
Barry, E., Roberts, S. A., Oke, J. L., Vijayaraghavan, S., Normansell, R., & Greenhalgh, T. (2017) · BMJ · doi:10.1136/bmj.i6538 · Cited by 347
Exercise or exercise and diet for preventing type 2 diabetes mellitus
Orozco, L. J., Buchleitner, A. M., Giménez‐Pérez, G., Figuls, M. R. I., Richter, B., & Mauricio, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub3 · Cited by 346
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
A systematic review of real-world diabetes prevention programs: learnings from the last 15 years
Aziz, Z., Absetz, P., Oldroyd, J. C., Pronk, N. P., & Oldenburg, B. F. (2015) · Implementation Science · doi:10.1186/s13012-015-0354-6 · Cited by 318
Greaves, C. J., Gillison, F., Stathi, A., Bennett, P., Reddy, P., Dunbar, J., Perry, R. A., Messom, D., Chandler, R., Francis, M., et al. (2015) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-014-0159-z · Cited by 302
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub6 · Cited by 296
Talmud, P. J., Hingorani, A. D., Cooper, J. A., Marmot, M. G., Brunner, E. J., Meena Kumari, B., Mika Kivimaki, B., & Humphries, S. E. (2010) · BMJ · doi:10.1136/bmj.b4838 · Cited by 297
Gillies, C., Lambert, P. C., Abrams, K. R., Sutton, A. J., Cooper, N. J., Hsu, R. T., Davies, M. J., & Khunti, K. (2008) · BMJ · doi:10.1136/bmj.39545.585289.25 · Cited by 293
Self-citationAl‐Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Yousef, M., Sabico, S., & Chrousos, G. P. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-76 · Cited by 290
Forouhi, N. G., & Wareham, N. J. (2018) · Medicine · doi:10.1016/j.mpmed.2018.10.004 · Cited by 289
Health Psychology: The Search for Pathways between Behavior and Health
Leventhal, H., Weinman, J. A., Leventhal, E. A., & Phillips, L. A. (2007) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093643 · Cited by 289
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis
Cooper, A., Forouhi, N. G., Ye, Z., Buijsse, B., Arriola, L., Balkau, B., Barricarte, A., Beulens, J. W. J., Boeing, H., Büchner, F. L., et al. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.85 · Cited by 282
The impact of sugar consumption on stress driven, emotional and addictive behaviors
Jacques, A., Chaaya, N., Beecher, K., Ali, S. A., Belmer, A., & Bartlett, S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.021 · Cited by 271
Forouhi, N. G., Ye, Z., Rickard, A. P., Khaw, K., Luben, R., Langenberg, C., & Wareham, N. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2544-y · Cited by 268
The prevention of type 2 diabetes
F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0843 · Cited by 261
Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity
Seifarth, C., Schehler, B., & Schneider, H. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1327734 · Cited by 258
Expert panel report: Guidelines (2013) for the management of overweight and obesity in adults
(2014) · Obesity · doi:10.1002/oby.20660 · Cited by 257
Molecular mechanisms of chromium in alleviating insulin resistance
Hua, Y., Clark, S., Ren, J. T., & Sreejayan, N. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.11.001 · Cited by 263
Tamayo, T., Rosenbauer, J., Wild, S. H., Spijkerman, A. M. W., Baan, C. A., Forouhi, N. G., Herder, C., & Rathmann, W. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.007 · Cited by 268
Cooper, A., Sharp, S. J., Lentjes, M. A. H., Luben, R., Khaw, K., Wareham, N. J., & Forouhi, N. G. (2012) · Diabetes Care · doi:10.2337/dc11-2388 · Cited by 255
Yates, T. E., Zaccardi, F., Dhalwani, N. N., Davies, M. J., Bakrania, K., Celis-Morales, C. A., Gill, J. M. R., Franks, P. W., & Khunti, K. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx449 · Cited by 243
Self-citationTake Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe
Lindström, J., Neumann, A., Sheppard, K. E., Gilis‐Januszewska, A., Greaves, C. J., Handke, U., Pajunen, P., Puhl, S., Pölönen, A., Rissanen, A., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240975 · Cited by 236
Garber, A. J., Handelsman, Y., EINHORN, D. F., Bergman, D. A., Bloomgarden, Z. T., Fonseca, V. A., Garvey, W. T., Gavin, J. R., Grunberger, G., Horton, E. S., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.7.933 · Cited by 239
Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Langenberg, C., Sharp, S. J., Franks, P. W., Scott, R. A., Deloukas, P., Forouhi, N. G., Froguel, P., Groop, L., Hansen, T. F., Palla, L., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001647 · Cited by 237
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
Bellentani, S., Grave, R. D., Suppini, A., & Marchesini, G. (2007) · Hepatology · doi:10.1002/hep.22009 · Cited by 238
pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 239
Gregg, E. W., Buckley, J., Ali, M. K., Davies, J. I., Flood, D., Mehta, R., Griffiths, B., Lim, L., Manne‐Goehler, J., Pearson‐Stuttard, J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00001-6 · Cited by 267
Chronic kidney disease in low-income to middle-income countries: the case for increased screening
George, C., Mogueo, A., Okpechi, I. G., Echouffo-Tcheugui, J. B., & Kengne, A. P. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2016-000256 · Cited by 231
Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes
Maggard-Gibbons, M. A., Maglione, M., Livhits, M. J., Ewing, B. A., Maher, A. R., Hu, J., Li, Z., & Shekelle, P. (2013) · JAMA · doi:10.1001/jama.2013.4851 · Cited by 226
Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes
Wallin, A., Giuseppe, D. D., Orsini, N., Patel, P. S., Forouhi, N. G., & Wolk, A. (2012) · Diabetes Care · doi:10.2337/dc11-1631 · Cited by 226
Type 2 diabetes and cardiovascular disease in South Asians
Gholap, N. N., Davies, M. J., Patel, K., Sattar, N. A., & Khunti, K. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.08.002 · Cited by 224
Self-citationYates, T. E., Davies, M. J., Gorely, T., Bull, F., & Khunti, K. (2009) · Diabetes Care · doi:10.2337/dc09-0130 · Cited by 218
Self-citationManagement of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification
Magkos, F., Yannakoulia, M., Chan, J. L., & Mantzoros, C. S. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141200 · Cited by 217
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Kahn, H. S., Cheng, Y. J., Thompson, T. J., Imperatore, G., & Gregg, E. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00002 · Cited by 204
Gray, L. J., Taub, N. A., Khunti, K. K., Gardiner, E., Hiles, S., Webb, D. R., Srinivasan, B. T., & Davies, M. J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03037.x · Cited by 196
Self-citationPolycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C. S., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A. “. J., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 218
Integrated behavioral health in primary care: Step-by-step guidance for assessment and intervention.
Hunter, C. L., Goodie, J. L., Oordt, M. S., & Dobmeyer, A. C. (2016) · American Psychological Association eBooks · doi:10.1037/0000017-000 · Cited by 193
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Domecq, J. P., Prutsky, G., Mullan, R. J., Hazem, A., Sundaresh, V., Elamin, M. B., Phung, O. J., Wang, A., Hoeger, K., Pasquali, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2385 · Cited by 184
Phung, T. L., Anothaisintawee, T., Chaikledkaew, U., Briones, J. R., Reutrakul, S., & Thakkinstian, A. (2020) · Nutrients · doi:10.3390/nu12092722 · Cited by 204
Liu, Y., Ye, W., Chen, Q., Zhang, Y., Kuo, C.-H., & Korivi, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010140 · Cited by 176
The Role of Zinc and Copper in Insulin Resistance and Diabetes Mellitus
Bjørklund, G., Dadar, M., Pivina, L. M., Doşa, M. D., Semenova, Y. M., & Aaseth, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190902122155 · Cited by 178
Bergman, M., Manco, M., Satman, İ., Chan, J. C. N., Schmidt, M. I., Sesti, G., Fiorentino, T. V., Abdul-Ghani, M. A., Jagannathan, R., Pramodkumar, T. A., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111589 · Cited by 198
Kengne, A. P., Beulens, J. W. J., Peelen, L. M., Moons, K. G. M., van der Schouw, Y. T., Schulze, M. B., Spijkerman, A. M. W., Griffin, S. J., Grobbee, D. E., Palla, L., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70103-7 · Cited by 173
Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention
Tuomilehto, J. O., Schwarz, P. E. H., & Lindström, J. (2011) · Diabetes Care · doi:10.2337/dc11-s222 · Cited by 175
Lindström, J., Peltonen, M., Eriksson, J. G., Aunola, S., Hämäläinen, H., Ilanne‐Parikka, P., Keinanen-Kiukaanniemi, S. M., Uusitupa, M. I. J., Tuomilehto, J. O., & for the Finnish Diabetes Prevention Study (DPS) Group (2008) · Diabetes Care · doi:10.2337/dc07-2162 · Cited by 163
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
Herder, C., Karakas, M., & Köenig, W. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.93 · Cited by 168
Forouhi, N. G., & Wareham, N. J. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.007 · Cited by 178
Díaz-López, A., Bulló, M., Martínez-González, M. A., Corella, D., Estruch, R., Fitó, M., Gómez-Gracia, E., Fiol, M., García de la Corte, F. J., Ros, E., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-015-0855-8 · Cited by 165
Gakidou, E. E., Mallinger, L., Abbott-Klafter, J., Guerrero, R., Villalpando, S., López‐Ridaura, R., Aekplakorn, W., Naghavi, M., Lim, S. S., Lozano, R., et al. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.10.080820 · Cited by 159
Baker, M. K., Simpson, K. A., Lloyd, B. D., Bauman, A. E., & Singh, M. A. F. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.06.030 · Cited by 161
Evidence-based practice guideline for the treatment for diabetes in Japan 2013
Tajima, N., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Fujimoto, K., Sakamoto, M., & Haneda, M. (2015) · Diabetology International · doi:10.1007/s13340-015-0206-2 · Cited by 154
Slawson, D. L., Fitzgerald, N., & Morgan, K. T. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.05.005 · Cited by 153
Obesity and late-onset hypogonadism
Corona, G., Vignozzi, L., Sforza, A., Mannucci, E., & Maggi, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.031 · Cited by 154
Penn, L., White, M. J., Oldroyd, J. C., Walker, M., Alberti, K. G. M. M., & Mathers, J. C. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-342 · Cited by 157
England, L. J., Dietz, P. M., Njoroge, T., Callaghan, W. M., Bruce, C., Buus, R. M., & Williamson, D. F. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.031 · Cited by 154
Diabetes Mellitus: Screening and Diagnosis.
Pippitt, K. A., Li, M., & Gurgle, H. E. (2016) · PubMed · Cited by 153
for the Japan Diabetes Complications Study Group, Sone, H., Tanaka, S., Iimuro, S., Tanaka, S., Oida, K., Yamasaki, Y., Oikawa, S., Ishibashi, S., Katayama, S., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1622-2 · Cited by 151
Sarrafzadegan, N. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.07.049841 · Cited by 153
Dunkley, A. J., Charles, K., Gray, L. J., Camosso‐Stefinovic, J., Davies, M. J., & Khunti, K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01571.x · Cited by 151
Self-citationHopper, I., Billah, B., Skiba, M., & Krum, H. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711421687 · Cited by 149
Cardona-Morrell, M., Rychetnik, L., Morrell, S. L., Espinel, P. T., & Bauman, A. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-653 · Cited by 147
Metadata
- Authors
- Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K.
- Affiliations
- University of Leicester (GB)
- Corresponding author
- Gillies, Clare L
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2007-01-19
- Volume
- 334
- Issue
- 7588
- Pages
- 299
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC1796695
- OpenAlex
- W2096691922
- Cited by
- 1,171
- References
- 43
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 38 · 2023: 38 · 2022: 40 · 2021: 47 · 2020: 56 · 2019: 56 · 2018: 51 · 2017: 78 · 2016: 74 · 2015: 75 · 2014: 98 · 2013: 97 · 2012: 100
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Medical Research Council
- Economic and Social Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- type 2 diabetes prevention, impaired glucose tolerance, lifestyle intervention, pharmacological interventions, oral antidiabetic drugs, orlistat, diabetes progression, number needed to treat
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Life Style, Randomized Controlled Trials as Topic, Treatment Outcome, Publication Bias, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review